Intelligence Driven Advisers LLC Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Intelligence Driven Advisers LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 9.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 496 shares of the healthcare conglomerate’s stock after acquiring an additional 44 shares during the quarter. Intelligence Driven Advisers LLC’s holdings in UnitedHealth Group were worth $251,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Avestar Capital LLC boosted its stake in shares of UnitedHealth Group by 7.6% during the 4th quarter. Avestar Capital LLC now owns 7,304 shares of the healthcare conglomerate’s stock worth $3,695,000 after acquiring an additional 518 shares during the last quarter. Hemington Wealth Management lifted its position in UnitedHealth Group by 5.9% during the fourth quarter. Hemington Wealth Management now owns 1,126 shares of the healthcare conglomerate’s stock valued at $569,000 after purchasing an additional 63 shares in the last quarter. Ingalls & Snyder LLC increased its position in UnitedHealth Group by 1.7% in the fourth quarter. Ingalls & Snyder LLC now owns 8,670 shares of the healthcare conglomerate’s stock worth $4,386,000 after buying an additional 143 shares in the last quarter. McClarren Financial Advisors Inc. lifted its position in shares of UnitedHealth Group by 62.7% during the 4th quarter. McClarren Financial Advisors Inc. now owns 1,533 shares of the healthcare conglomerate’s stock valued at $775,000 after buying an additional 591 shares in the last quarter. Finally, Hidden Cove Wealth Management LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $214,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 1.2 %

UNH stock opened at $527.31 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm’s fifty day simple moving average is $524.58 and its two-hundred day simple moving average is $563.71. The stock has a market capitalization of $485.27 billion, a price-to-earnings ratio of 34.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analyst Ratings Changes

UNH has been the subject of a number of recent analyst reports. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Oppenheimer upped their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. KeyCorp reissued an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.